EFFICACY OF DUAL ANTI-PLATELET THERAPY IN CORONARY ARTERY BYPASS GRAFT PATIENTS WITH STABLE ISCHEMIC HEART DISEASE

被引：0

作者：

Ch , Iftikhar A. ^{[1
]}

Tahirkheli, Naeem ^{[1
]}

Latif, Faisal ^{[1
]}

Usmani, Ahmad ^{[1
]}

Tahirkheli, Mashal ^{[1
]}

Amil, Faris ^{[1
]}

Chaudry, Sabrina ^{[1
]}

Bhaktaram, Ananya ^{[1
]}

Whitehead, Aldon ^{[1
]}

Weitzel, Hunter ^{[1
]}

Ullah, Raja ^{[1
]}

Qadar, Abdul ^{[1
]}

Wu, Pei-Tzu ^{[1
]}

Ijaz, Haris ^{[1
]}

Garrett, Jeffrey ^{[1
]}

机构：

[1] Oklahoma Heart Res Fdn, Oklahoma City, OK USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1129-367

引用

页码：44 / 44

页数：1

共 50 条

[31] Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease
Li Wei-ju
Zhang Hong-yin
Miao Cheng-long
Tang Ri-bo
Du Xin
Shi Ji-hui
Ma Chang-sheng
CHINESE MEDICAL JOURNAL, 2011, 124 (10) : 1569 - 1572
[32] Impact of systolic blood pressure on hemorrhagic stroke in patients with coronary artery disease during anti-platelet therapy: The Japanese Coronary Artery Disease (JCAD) study
Kai, Hisashi
Kohro, Takahide
Fukuda, Kenji
Yamazaki, Tsutomu
Nagai, Ryozo
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 224 : 112 - 113
[33] SHOULD DUAL ANTI-PLATELET THERAPY FOR CORONARY ARTERY DISEASE BE MORE OR LESS THAN 12 MONTHS? : A META-ANALYSIS
Garcia, D.
Ansari, M.
Martinez, C.
Alfonso, C.
Benjo, A.
Cohen, M.
De Marchena, E.
CARDIOLOGY, 2014, 128 : 458 - 458
[34] Optimizing Anti-Platelet Therapy for Patients with At-Risk Acute Coronary Syndrome The Era of Triple Anti-Platelet Therapy Introduction
Gibson, C. Michael
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0D) : D1 - D3
[35] GRAFT DISEASE IN CORONARY-ARTERY BYPASS PATIENTS
FERGUSON, TB
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1987, 93 (06): : 942 - 943
[36] Bleeding Risks for Acute Ischemic Stroke Patients on Serotonergic Antidepressants and Anticoagulation/Dual Anti-Platelet Therapy
Simmonds, Kent P.
Chavez, Audrie
Fejika, Nneka L.
STROKE, 2024, 55
[37] Drug interactions in the setting of acute coronary syndromes and dual anti-platelet therapy
Bassand, Jean-Pierre
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0G) : G35 - G37
[38] The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy
Warner, Timothy D.
Armstrong, Paul C.
Chan, Melissa V.
Knowles, Rebecca B.
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (03) : 223 - 225
[39] IMPROVED GRAFT PATENCY WITH ANTI-PLATELET DRUGS IN PATIENTS TREATED FOR ONE YEAR FOLLOWING CORONARY-BYPASS SURGERY
BROWN, BG
CUKINGNAN, RA
GOEDE, L
WONG, M
FEE, H
ROTH, J
WITTIG, J
CAREY, J
AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02): : 494 - 494
[40] Differences in high on-treatment platelet reactivity between intra-coronary and peripheral blood after dual anti-platelet agents in patients with coronary artery disease
Hu, Yu-Feng
Lu, Tse-Min
Wu, Cheng-Hsueh
Lin, Yenn-Jiang
Chang, Shih-Lin
Lo, Li-Wei
Tuan, Ta-Chuan
Chao, Tze-Fan
Chung, Fa-Po
Liao, Jo-Nan
Tzeng, Cheng-Hwai
Chen, Shih-Ann
Tsao, Hsuan-Ming
THROMBOSIS AND HAEMOSTASIS, 2013, 110 (01) : 124 - 130

← 1 2 3 4 5 →